Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-09-03

Clinical Trial Update: Capsaicin in Treatment of Rhinogenic Headache [NA]

View source ↗

Summary

A University of Nebraska-sponsored clinical trial evaluating capsaicin for rhinogenic headache has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capsaicin (capsaicin)

Snippet

Sponsor: University of Nebraska | Conditions: Headache Disorders | NA | Status: WITHDRAWN